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Understanding the underlying mechanisms of cell injury and death induced by the chemical warfare
vesicant sulfur mustard (HD) will be extremely helpful in the development of effective countermeasures
to this weapon of terror. We have found recently that HD induces both apoptosis and necrosis in
endothelial cells (Toxicol. Appl. Pharmacol.1996; 141: 568–583). Pretreatment of the endothelial cells
for 20 h with the redox-active agent N-acetyl-l-cysteine (NAC) selectively prevented apoptotic death
induced by HD. In this study, we tested the hypotheses that pretreatment with NAC acts through two
different pathways to minimize endothelial injury by HD: NAC pretreatment acts via a glutathione
(GSH)-dependent pathway; and NAC pretreatment acts to suppress HD-induced activation of the nuclear
transcription factor NF kB. We used a fluorescence microscopic assay of apoptotic nuclear features to
assess viability and electrophoretic mobility shift assays (EMSAs) to assess the activity of NFkB following
exposure to HD. The cells were treated with 0–10 mM GSH for 1 h prior to and during exposure to 0
or 500 mM HD for 5–6 h. Cells were also treated with 50 mM NAC or 200mM buthionine sulfoximine
(BSO), an inhibitor of GSH synthesis, alone or in combination overnight prior to exposure to 0 or
500mM HD for 5–6 h. Externally applied GSH up to a concentration of 5 mM had no toxic effect on
the cells. Mild toxicity was associated with 10 mM GSH alone. There was a dose-related enhancement
of viability when 2.5 and 5 mM GSH were present during the HD exposure. Pretreatment with BSO
alone had no discernible toxicity. However, pretreatment with this inhibitor of GSH synthesis potentiated
the toxicity of HD. Pretreatment with 50 mM NAC, as previously reported, provided substantial
protection. Combining pretreatment with both BSO and NAC eliminated the protective effect of NAC
pretreatment alone on HD injury. These observations are highly suggestive that NAC enhances endo-
thelial survival via GSH-dependent effects and confirms and extends the work of others with different
models that externally supplied GSH alone may be a fairly effective countermeasure against HD injury
of endothelium. We next examined the hypothesis that HD may activate the nuclear transcription factor
NFkB by performing EMSAs with nuclear extracts of endothelial cells following exposure to 0, 250 or
500mM HD. This demonstrated an up to 2.5-fold increase (scanning densitometry) in activation of
NFkB binding to its consensus sequence induced by 500mM HD after 5 h of HD exposure. Paradoxically,
treatment of the endothelial cells alone with 50 mM NAC activated NFkB, although HD-induced
activation of NFkB was partially suppressed by NAC at 5 h. Factor NFkB is an important transcription
factor for a number of cytokine genes (e.g. tumor necrosis factor, TNF), which can be activated
following stress in endothelial cells. Taken together, these observations suggest that the protective effects
of NAC may be mediated by enhanced GSH synthesis. The increased GSH may act to scavenge HD
and also prevent oxidative activation of NFkB. Under some conditions, NAC may act as an oxidizing
agent and thus increase NFkB activity. The NFkB-dependent gene expression may be important in
inducing endothelial cell death as well as in generating a local inflammatory reaction associated with
the release of endothelial-derived cytokines. Copyright 2000 John Wiley & Sons, Ltd.
INTRODUCTION
In recent years there has been a growing concern about
the proliferation of chemical weapons and an increasing
interest in the ability to combat them. One such agent,
sulfur mustard (HD), is used as a vesicant. Sulfur
mustard is both mutagenic and carcinogenic, most
likely as a result of DNA damage due to alkylation.1
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Exposure to HD causes irritation, edema, vesication,
ulceration and ultimately necrosis. These effects are
dependent upon the dose and location of HD exposure.
Endothelial cells are one target of HD-mediated
injury. Increased capillary leakage has been observed
during HD injury.2 We have also found that cultured
vascular endothelial cell monolayers demonstrate
increased permeability in response to HD.3 This
increased permeability may be the result of altered
endothelial morphology. Vascular endothelial cells
exposed to HD undergo microtubule depolymerization,
disruption of long actin filament stress fibers, loss of
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adherence and ultimately apoptosis or necrosis.4 N-
Acetylcysteine (NAC) induces reorganization of endo-
thelial stress fiber networks and prevents HD-induced
cellular rounding, loss of adherence and apoptosis.4
N-Acetylcysteine is an antioxidant and redox-active
agent reported to prevent apoptosis in lymphocytes,
neurons and vascular endothelial cells.5 In addition,
this thiol-containing compound is a precursor for gluta-
thione synthesis. Glutathione, a cysteine-containing tri-
peptide, plays an important role in the detoxification
of xenobiotics and in the scavenging of reactive oxygen
species and free radicals. It has been demonstrated that
some of the major metabolic products of HD are
glutathione conjugates6 and that HD is excreted as a
glutathione metabolite.7 In rat lung tissue slices
exposed to HD there was a depletion of intracellular
glutathione.8 Glutathione levels are reduced in neuro-
blastoma–glioma hybrids and human peripheral lym-
phocytes exposed to HD.9,10
Sulfur mustard exposure of the human keratinocyte
cell line SVK-14 is accompanied by decreased
viability.11 Pretreatment with glutathione increased the
survivability of SVK-14 cells exposed to HD. Pretreat-
ment of cultured rat lung slices with cysteine esters,
which raise cellular cysteine levels available for gluta-
thione synthesis, is reported to be protective in HD
injury.12 Reciprocally, reduction of cellular glutathione
prior to HD exposure sensitized cells to the cytotoxic
effects of HD.10 In these same experiments, pretreat-
ment with NAC, which raised intracellular glutathione,
was protective against HD-induced cytotoxicity. There-
fore, it was of interest to determine in our model
whether there is any relationship between the protective
effects of NAC and glutathione levels. Furthermore,
depletion of glutathione is associated with potentiation
of tumor-necrosis-factor-mediated activation of the
transcription factor NFkB in L6 myoblasts.13 Because
NAC has been demonstrated to inhibit the activation
of NFkB, we investigated whether this transcription
factor might be activated in response to HD injury.
METHODS AND MATERIALS
Cell culture
Bovine pulmonary artery endothelial cells (National
Institute of Aging, Aging Cell Culture Repository,
Camden, NJ) were grown in F12 (Ham) nutrient mix-
ture supplemented with 10% fetal bovine serum and
antibiotics (Gibco, Grand Island, NY) and maintained
at 37°C under a 5% CO2-humidified atmosphere. Cells
were passaged using 0.05% trypsin and 0.02% EDTA
(Gibco) and were at confluence for all experiments
reported herein.
Cell viability
Confluent endothelial cells pretreated or not with gluta-
thione-modifying agents were subsequently treated with
or without 500mM HD for 6 h. The medium was then
removed and saved and the cells were harvested using
trypsin/EDTA. The harvested cells and media were
centrifuged and the resulting pellet resuspended. An
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aliquot was stained with a dye mixture (10mM acridine
orange and 10mM ethidium bromide) and examined
by fluorescence microscopy according to the criteria
described previously.4
Glutathione assay
Endothelial cells treated with or without 500mM HD
in the presence or absence of pretreatment were har-
vested as described above. The cell pellet (0.25–0.53
106 cells) was resuspended in 50ml of 0.2% Triton-
X100 containing 2.5% sulfosalicylic acid. The cells
were vortexed and then centrifuged at 12000 rpm for
5 min. Then 25ml of supernatant was transferred to a
tube. Total cellular glutathione (GSH) was subsequently
measured as described.14
Electrophoretic mobility shift assay
Confluent endothelial cells were treated with or without
50 mM NAC for at least 16 h. Cells were then treated
with or without 250mM HD or 500mM HD for 2 or
5 h. Cells were harvested by scraping and the cells
and media were pelleted. The pellet was processed for
nuclear protein as described.15 The nuclear extracts
were normalized for protein content (Bio-Rad, Her-
cules, CA) and analyzed for binding to a radiolabeled
consensus nuclear factor sequence (NFkB; 59GGG-
GACTTTCCGCTGGGGACTTTCCAGGGGGACTTTCC
39) as described.16 Specific binding was determined
utilizing a 100-fold excess unlabeled NFkB sequence.
Statistics
Data were analyzed by a two-tailed Student’st-test.
RESULTS
Effects of glutathione-altering conditions on
endothelial cell viability following Sulfur mustard
exposure
The agents buthionine sulfoximine (BSO) and NAC
were used to alter the synthesis of GSH in endothelial
cells prior to HD exposure. Pretreatment of the endo-
thelial cells with 0.2 mM BSO (a specific inhibitor of
g-glutamyl cysteine synthetase) did not alter the
viability of uninjured control endothelial cells (Table
1). However, GSH depletion with BSO pretreatment
did potentiate the toxic effect of 500mM HD on
endothelial viability, which was largely demonstrated
as an increase in the number of necrotic cells detected
6 h after HD exposure (Table 1). The increased
viability of endothelial cells exposed to 500mM HD
that had been pretreated with 50 mM NAC was abro-
gated by concurrent pretreatment with BSO (Table 1).
When exogenous GSH (0–10 mM) was present dur-
ing HD exposure, there was a dose-dependent increase
in survival of endothelial cells exposed to 500mM HD
detected at 6 h, although with 10 mM GSH there was
some associated toxicity detected, even in the control,
which diminished some of the dose-related benefits
seen with the lower concentrations of GSH (Table 2).
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Table 1. Effects of buthionine sulfoximine (BSO) andN-acetylcysteine (NAC) on sulfur-mustard (HD) treated endo-
thelial cellsa
Control 500 mM HD
% V % A % N % V % A % N
Untreated 90.3 6 3.1 3.6 6 2.1 6.1 6 2.8 50.4 6 4.0 33.1 6 5.0 16.3 6 4.5
0.2 mM BSO 91.0 6 3.0 2.7 6 0.6 6.3 6 3.1 35.7 6 8.4 32.7 6 10.3 31.7 6 17.8
50 mM NAC 93.3 6 3.6 2.5 6 1.0 4.3 6 2.6 69.3 6 1.7 21.2 6 4.3 9.5 6 4.4
BSO 1 NAC 92.7 6 4.0 2.0 6 1.0 5.3 6 3.2 51.7 6 4.7 37.0 6 5.7 11.3 6 1.2
aConfluent endothelial cells were pretreated with or without 0.2 mM BSO for at least 6 h prior to treatment with or without 50 mM
NAC for 16 h. The medium was changed, followed by treatment with or without 500 mM HD for 6 h. Cell viability was determined
as described in Methods and Materials: V, viable; A, apoptotic; N, necrotic. Values reported as mean 6 SD (n = 4).
Table 2. Effect of exogenous glutathione (GSH) on sulfur-mustard (HD)-induced injury in endothelial cellsa
Control 500 mM HD
% V % A % N %V %A %N
GSH (mM)
0 90.3 6 3.1 3.6 6 2.1 6.1 6 2.8 50.4 6 4.0 33.1 6 5.0 16.3 6 4.5
2.5 88.0 6 0.0 5.0 6 2.6 7.0 6 2.6 72.7 6 5.9 15.7 6 5.5 11.7 6 4.2
5.0 88.0 6 5.5 4.8 6 2.5 9.8 6 5.6 75.4 6 5.6 11.3 6 1.3 11.3 6 4.2
10.0 83.0 6 4.0 4.0 6 1.7 13.3 6 3.0 66.7 6 6.4 10.7 6 3.2 23.0 6 3.6
aConfluent endothelial cells were pretreated with 0–10 mM GSH for 1 h. The cells were then treated with or without 500 mM HD
for 6 h without a medium change. Cell viability was determined as described in Methods and Materials: V, viable; A, apoptotic;
N, necrotic. Values reported as mean 1 SD (n = 4).
Effects of glutathione-altering agents on total
cellular glutathione levels in sulfur-mustard-
injured endothelial cells
When intracellular GSH levels were measured, it was
determined that NAC pretreatment alone was associated
with an approximate 60% increase in GSH levels in
uninjured endothelial cells (Fig. 1). Treatment with
BSO alone or in combination with NAC in uninjured
endothelial cells was associated with a substantial
reduction of approximately 60% of total intracellular
Figure 1. Effects of buthionine sulfoximine (BSO) and N-acetyl-
cysteine (NAC) on glutathione (GSH) levels in endothelial cells.
Cells were treated with or without 0.2 mM BSO for 6 h prior
to additional treatment with or without 50 mM NAC for 16 h.
The medium was changed and cells were treated with or
without 500 mM HD for 6 h. Total cellular GSH was determined
as described in Methods and Materials (n = 3): *P < 0.02 vs
(2HD) control; **P < 0.005 vs (2HD) NAC; (*)P < 0.02 vs
(1HD) control; (**)P < 0.005 vs (1HD) NAC.
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GSH levels. Total GSH levels following exposure to
500mM HD were reduced significantly in endothelial
cells (ca. 40%), but were substantially preserved in
endothelial cells pretreated with 50 mM NAC prior to
HD exposure (Fig. 1).
Effect of Sulfur mustard on nuclear transcription
factor NFkB activity in endothelial cells
Nuclear transcription factor NFkB activity was meas-
ured using electrophoretic mobility shift assays in
experiments where endothelial cells were exposed to
250 or 500mM HD and nuclear extracts were made
at 2 or 5 h after exposure to the vesicant with or
without prior treatment with 50 mM NAC. An increase
in NFkB binding to its consensus sequence was
detected in extracts taken from cells exposed to
500mM HD as early as 2 h, with an increase seen at
5 h. The NAC treatment in combination with HD
exposure was associated with variable effects on the
NFkB activity induced by HD alone (Fig. 2). Not until
5 h after exposure to 500mM HD was there any
inhibitory effect (88% reduction in NFkB activity vs
HD alone by scanning densitometry) of NAC treatment
on NFkB activity (Fig. 2). Interestingly, NAC treatment
alone was associated with a 52% increase in NFkB
activity compared with the control (Fig. 2).
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Figure 2. Electrophoretic mobility shift analysis of nuclear
extracts of endothelial cells exposed to sulfur mustard (HD).
Confluent endothelial cells were pretreated with or without
50 mM N-acetylcysteine (NAC) for at least 16 h. Cells were
then treated with 0, 250 or 500 mM HD for 2 or 5 h without a
medium change. Nuclear extracts were prepared and 5 mg of
protein was incubated with a 32P-labeled consensus NFkB
oligonucleotide (30000 cpm) for 20 min at room temperature.
The binding reactions were then resolved by polyacrylamide
gel electrophoresis and exposed to X-ray film at 270°C. Num-
bers in parentheses represent the percentage increase of each
band compared with the control as determined by scanning
densitometry.
DISCUSSION
In this study we have confirmed and extended the
work of others demonstrating that exogenous GSH exerts
marked protective effects in cellular injury secondary to
HD exposure. The experiments with the GSH-altering
agents, NAC and BSO, confirm that at least part of the
beneficial effect of NAC on endothelial cell survival
following HD injury is directly related to its stimulatory
effect on GSH synthesis, because inhibition of the stimu-
latory effects of NAC on GSH synthesis by concurrent
treatment with BSO abrogated any beneficial effects on
endothelial cell viability and total GSH levels.
Our preliminary observations with electrophoretic
mobility shift assays of nuclear extracts from endo-
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